Gene · 1267
Papers3,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Superficial white matter analysis: An efficient point-cloud-based deep learning framework with supervised contrastive learning for consistent tractography parcellation across populations and dMRI acquisitions. | Med Image Anal | 2023 | 36706638 | PubTator, text mining | PubMed |
| The recent development of nanozymes for targeting antibacterial, anticancer and antioxidant applications. | RSC Adv | 2023 | 36688073 | PubTator, text mining | PubMed |
Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation. | Bioeng Transl Med | 2023 | 36684074 | PubTator, text mining | PubMed |
| DNA methylation of the promoter region at the CREB1 binding site is a mechanism for the epigenetic regulation of brain-specific PKMζ. | Biochim Biophys Acta Gene Regul Mech | 2023 | 36682583 | PubTator, text mining | PubMed |
| Synthesis of Cellulose Nanoparticles from Ionic Liquid Solutions for Biomedical Applications. | Polymers (Basel) | 2023 | 36679262 | PubTator, text mining | PubMed |
| DDR1 and Its Ligand, Collagen IV, Are Involved in In Vitro Oligodendrocyte Maturation. | Int J Mol Sci | 2023 | 36675255 | PubTator, text mining | PubMed |
| Myelinodegeneration vs. Neurodegeneration in MS Progressive Forms. | Int J Mol Sci | 2023 | 36675111 | PubTator, text mining | PubMed |
| Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology. | Bioengineering (Basel) | 2023 | 36671680 | PubTator, text mining | PubMed |
| Cerium Oxide Nanoparticles Conjugated with Tannic Acid Prevent UVB-Induced Oxidative Stress in Fibroblasts: Evidence of a Promising Anti-Photodamage Agent. | Antioxidants (Basel) | 2023 | 36671052 | PubTator, text mining | PubMed |
| The neuroprotective and neural circuit mechanisms of acupoint stimulation for cognitive impairment. | Chin Med | 2023 | 36670425 | PubTator, text mining | PubMed |
| Potentially toxic elements in the brains of people with multiple sclerosis. | Sci Rep | 2023 | 36635465 | PubTator, text mining | PubMed |
| Proteomic profiling of urinary small extracellular vesicles in children with pneumonia: a pilot study. | Pediatr Res | 2023 | 36635400 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease. | BMC Genomics | 2023 | 36624378 | PubTator, text mining | PubMed |
| Adaptive autophagy reprogramming in Schwann cells during peripheral demyelination. | Cell Mol Life Sci | 2023 | 36622429 | PubTator, text mining | PubMed |
| Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. | Microbiol Spectr | 2023 | 36602312 | PubTator, text mining | PubMed |
| Catalpol Mitigates Alzheimer's Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p. | Neurotox Res | 2023 | 36595161 | PubTator, text mining | PubMed |
| Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds. | J Cancer Res Clin Oncol | 2023 | 36562811 | PubTator, text mining | PubMed |
| Identifying Genes that Affect Differentiation of Human Neural Stem Cells and Myelination of Mature Oligodendrocytes. | Cell Mol Neurobiol | 2023 | 36547781 | PubTator, text mining | PubMed |
| The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. | Adv Sci (Weinh) | 2023 | 36529697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1267/papers?page=19